Link to Original Post: https://www.linkedin.com/posts/sk-group-media_mysk-activity-6889210467521196032-pLZT
#mySK Shelley Vogler Senior Production Planner profiled by SK Group Read More »
A word with…Aslam Malik PhD, CEO SK pharmteco After the acquisition of Yposkesi that allowed SK pharmteco to enter the Cell and Gene Therapy market, are there any other expansion plans you would like to highlight? This is an exciting area for us. Our goal is to become the largest global, end to end
ChimicaOggi|ChemToday Interview with Aslam Malik Read More »
SK Inc. to invest $350M through SK pharmteco. SK Inc. announced on January 9th that it has invested $350 million in the Center for Breakthrough Medicines (CBM), a Pennsylvania-based CGT CDMO, to become the second-largest shareholder…
SK Inc. to invest $350M through SK pharmteco Read More »
In a recent interview with Japan Chemical Daily, Aslam Malik, CEO of SK pharmteco, shares the company’s growth in Cell & Gene Therapy and plans to strengthen business in the Japanese market. Read the full article below: SK pharmteco, an US company engaged in CDMO business arm of the South Korean conglomerate SK Group, is making
Japan Chemical Daily Interview with Aslam Malik Read More »
Attending CPhI? Pop by Stand 2C46 to meet SK pharmteco’s Pedro Couto Rosado Director of Business Development and Yposkesi’s Dr Brian Mullan Head of Analytical and Process Development, Innovation, Cell and Gene Therapies to hear about #skpharmteco‘s global offering in cell and gene therapy – lentiviral vectors, adeno-associated viral vectors, continuous flow processing, chromatography, SMB, HPAPI, energetic chemistry, controlled substances
Click below to read an article published in the latest issue of tks | publisher, event organiser, media agency written by #SKpharmteco VP Research & Development William DuBay and SK biotek Ireland Limited Director of R&D Samuel Baron focused on ‘Handling HPAPIs for maximum manufacturing flexibility while maintaining adequate safety controls’. https://www.teknoscienze.com/tks_article/handling-hpapis-for-maximum-manufacturing-flexibility-while-maintaining-adequate-safety-controls/
Click here to see the full agenda and register.
SK pharmteco and Yposkesi are Proud to Sponsor PharmaTech Integrates Read More »
Press Release | For Immediate Release SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK biotek Ireland has been promoted to the office of President, SK biotek Ireland. Growth in our business base and projected expansions continue to support SK biotek Ireland’s position as a key contributor
SK pharmteco Announces Appointment of a New President for SK biotek Ireland Read More »
Read a CMO’s perspective on Continuous Process Implementation Recently published in TKS | publisher’s ChemicalToday click the link to read the article by Olivier Dapremont, Executive Director of AMPAC Fine Chemicals an SK pharmteco Company, and view the full supplement https://lnkd.in/efHDCqe
Continuous Process Implementation: A CMO Perspective Read More »
PETERSBURG, Va., June 17, 2021 The City of Petersburg, home to AMPAC Fine Chemicals Virginia, declared June 17, 2021 as “AMPAC Day”. An event was held in appreciation of AFC’s employees and to further cultivate a positive relationship with the local community.
Celebrating AMPAC Day in Petersburg, Virginia Read More »
"*" indicates required fields
